Retrospective Cohort Study
Copyright ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Feb 15, 2019; 10(2): 78-86
Published online Feb 15, 2019. doi: 10.4239/wjd.v10.i2.78
New results on the safety of laparoscopic sleeve gastrectomy bariatric procedure for type 2 diabetes patients
Ohad Guetta, Alex Vakhrushev, Oleg Dukhno, Amnon Ovnat, Gilbert Sebbag
Ohad Guetta, Alex Vakhrushev, Oleg Dukhno, Amnon Ovnat, Gilbert Sebbag, Department General Surgery B, Soroka University Medical Center, Be’er Sheva 8457108, Israel
Author contributions: Guetta O performed data collection, statistical analysis, and the writing of this article; Ovnat A and Vakhrushev A recruited the patients and performed all the operations as well as treated further complications and perioperative care; Sebbag G made critical revision of the article and final approval of the version to be published; Dukhno O contributed to this paper.
Institutional review board statement: This study was approved by the local institutional review board.
Informed consent statement: The study was exempt of signed informed consent according to the local Institutional Review Board Approval due to its retrospective nature.
Conflict-of-interest statement: The authors have no competing interests to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Ohad Guetta, MD, Surgeon, Department General Surgery B, Soroka University Medical Center, Rager Ave. 151, POB 151, Be’er Sheva 8457108, Israel. ohadgu@clalit.org.il
Telephone: +972-52-2523899 Fax: +972-8-6239930
Received: November 6, 2018
Peer-review started: November 6, 2018
First decision: November 29, 2018
Revised: January 8, 2019
Accepted: January 22, 2019
Article in press: January 23, 2019
Published online: February 15, 2019
Processing time: 103 Days and 23.4 Hours
ARTICLE HIGHLIGHTS
Research background

Bariatric surgery has been advocated as an effective therapy for type 2 diabetes mellitus (T2DM) in an abundance of studies. Nevertheless, when considering a modality of treatment, its benefits should be weighed against its risks.

Research motivation

The risks that lie in bariatric surgery in the subgroup of T2DM have not been thoroughly investigated. Complications after other types of surgery within this subgroup of patients has led us to believe that post-bariatric surgery complication rates may be elevated in T2DM patients.

Research objectives

The main objectives of the study were to evaluate any kind of postoperative complications in the T2DM group vs non-T2DM patients within 60 d of surgery. Any deviation from the normal postoperative course was considered a complication. Further categorization into mild and severe complications was performed. This categorization was based upon Clavien-Dindo classification which is a common postoperative complications grading system.

Research methods

All patients who underwent laparoscopic sleeve gastrectomy performed by three surgeons in a single institute were included. Data was extracted from a digitized database through specific queries regarding length of stay, imaging, reoperations, and readmissions in the first 60 d after the operation. Mortality was extracted from that system as well. Any case of deviation from the average length of stay (more than 3 d after operation), further imaging (no imaging is routinely performed after operation), reoperation, or readmission was studied carefully in order to define the exact type of complication and categorize as mild or severe.

Research results

Nine hundred and eighty-four patients underwent laparoscopic sleeve gastrectomy, among these 143 (14.5%) were diagnosed with T2DM. There were 19 complications in the T2DM group (13.3%) compared to 59 cases in the non-T2DM (7.0%). Out of 19 complications in the T2DM group, 12 were mild (8.4%) and 7 were severe (4.9%). Compared to the non-T2DM group, patients had a higher risk for mild complications (Odds-ratio 2.316, CI: 1.163-4.611, P = 0.017), but not for severe ones (P = 0.615). Any increase of 1% in hemoglobin A1c levels was associated with a 40.7% increased risk for severe complications (P = 0.013, CI: 1.074-1.843).

Research conclusions

In this study, we find that the rate of mild complications is increased in T2DM patients. It means that these patients will suffer more from problems such as dysphagia, surgical site infection, dehydration, pneumonia, and bleeding. But these complications can be treated easily and conservatively without the need for interventions under general anesthesia, reoperations, or prolonged ICU admissions. Together with our knowledge of significant weight loss and reduction in glycemic burden after bariatric surgery, we believe that these complications should be well tolerated in face of the potential long-term benefit of this therapy in this subgroup of patients.

Research perspectives

Another result of our study, that any elevation of 1% in HbA1c levels is associated with a 40.7% increased risk for severe complications should commence a process of evaluating preoperative diabetes control. We believe that in a future study, patients with relatively high HbA1c level (above 9%) should have a short course of pre-operative tight glycemic control tested against patients who do not receive this preoperative intervention. This will also help us understand the pathophysiology of diabetes in surgical patients, and whether complications are driven purely from glycemic control or from chronic micro- and macro-vascular damage associated with diabetes.